<DOC>
	<DOCNO>NCT00279721</DOCNO>
	<brief_summary>Resected well-differentiated thyroid neoplasm least one high risk feature receive adjuvant radiation use IMRT SIB . The acute toxicity locoregional control rate 2 year record .</brief_summary>
	<brief_title>Phase II Study IMRT With SIB Adjuvant Treatment High Risk Resected Well-differentiated Thyroid Cancer .</brief_title>
	<detailed_description>Resected well-differentiated thyroid neoplasm least one high risk feature receive adjuvant radiation use IMRT SIB . The acute toxicity locoregional control rate 2 year record .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>resect welldifferentiated throid cancer least one high risk feature locoregional recurrence medullary anaplastic thyroid cancer , unresectable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>thyroid neoplasm</keyword>
	<keyword>intensity modulate radiation</keyword>
	<keyword>radiotherapy</keyword>
</DOC>